跳至主要内容
临床试验/NCT05450224
NCT05450224撤回不适用

Telehealth-delivered Massed Imaginal Exposure for PTSD: Toward Increasing Access to Alternative, Evidence-based Treatment Schedules for Virtual Care

Medical University of South Carolina0 个研究点开始时间: 2023年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
Rate of treatment completion and pre-mature dropout.

研究概览

简要总结

The purpose of this study is to establish the safety, feasibility, and acceptability of very brief imaginal exposure therapy for post-traumatic stress disorder (PTSD) delivered by telehealth over the course of six-daily 60-minute sessions within a 10-day window. All study visits occur remotely, by telehealth. You will be asked to complete a pre-treatment assessment involving a clinical interview, video-based measures of emotional and physical reactions, such as heart rate and breathing rate, and self-report questionnaires to measure the severity and impact of trauma-related symptoms. These assessments are completed again 1-week, and 1-month after completing treatment. The researchers propose that massed exposure-based therapy delivered via telehealth will advance telemental health treatment options and personalized care for Veterans with PTSD.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ability to speak, read, and write English.
  • Diagnosis of PTSD based on CAPS-5 (> 3 mo. post-trauma).
  • Seeking treatment for PTSD at the Charleston VA.
  • Willingness and ability to engage in assessment and treatment visits through VVC, or another VA-approved telehealth videoconferencing platform.

排除标准

  • Currently receiving psychotherapy for another anxiety- or stress-related condition.
  • Current substance use disorder diagnosis with repeated abuse or dependence within 3 months of study entry and unwillingness to abstain for 24 hours prior to study visits.
  • Unstable dose of psychotropic medications within 6 weeks prior to baseline assessment (based on the DMSC; see measures).
  • Medical condition that would contraindicate participation in treatment or assessment activities (e.g., severe cardiovascular problems; DMSC, and chart review; see measures).
  • Current, or history of bipolar I disorder
  • Current, or history of psychotic symptoms
  • Serious suicidal risk or a suicide attempt in the past year, as determined by self-report (PHQ-9) and clinical interview (C-SSRS; see measures).
  • Active neurological conditions, e.g., seizures, stroke, loss of consciousness or concussion (DMSC, and chart review; see measures)

结局指标

主要结局

Rate of treatment completion and pre-mature dropout.

时间窗: from pre-treatment to 1-month follow-up

Total percent of patients retained from initial patients.

PTSD symptom checklist

时间窗: from pre-treatment to 1-month follow-up

PCL-5: PTSD Symptom Checklist for DSM-5. Scores range from 0 to 80, with higher scores indicating greater PTSD severity and impairment.

Satisfaction with treatment - provider

时间窗: 1 week post-treatment

PETQ: Prolonged exposure therapist questionnaire; scores range 0-30 with higher scores suggesting patient is more engaged in treatment.

Satisfaction with treatment - patient

时间窗: 1 week post-treatment

STTSR: Satisfaction with Therapy and Therapist Scale-Revised; scores range 0-60 with higher scores indicating higher satisfaction

Adverse events

时间窗: from admission to 1 month follow up

Potential adverse events will be assessed with a structured as well as open-ended interview daily during treatment and at follow up.

Satisfaction with telehealth - patient

时间窗: 1 week post-treatment

Technology Treatment Satisfaction Questionnaire; scores range 0-60 with higher scores indicating higher satisfaction.

Satisfaction with telehealth - provider

时间窗: 1 week post-treatment

TTSQ-Provider: Technology Treatment Satisfaction Questionnaire; scores range 0-30 with higher scores suggesting patient is more engaged in treatment

CAPS: Clinician-Administered PTSD Scale for DSM-5

时间窗: from pre-treatment to 1-month follow-up

Structured interview for DSM-5 PTSD severity and impairment; Scores range from 0 to 80 with higher scores indicating greater PTSD severity and impairment.

Number of sessions attended per patient

时间窗: from pre-treatment to 1-month follow-up

Number of telehealth therapy appointments attended per patient.

次要结局

  • Facial emotional expressivity(Pre-treatment, 1-week post-treatment, and 1-month follow-up.)
  • Remote photoplethysmography(Pre-treatment, 1-week post-treatment, and 1-month follow-up.)
  • Vocal and linguistic emotional expressivity(Pre-treatment, 1-week post-treatment, and 1-month follow-up.)

研究者

申办方类型
Other
责任方
Sponsor

相似试验